mRNA Vaccinations vs COVID-19 Risk in Teens – Vaccinations are Safer

Case Western Reserve University researchers have demonstrated that the risk for myocarditis/pericarditis (heart inflammation) among male teens (12-17) diagnosed with COVID-19 is nearly 6 times higher than their combined risk following first and second doses of an mRNA COVID-19 vaccination.
The risk for myocarditis/pericarditis among girls (ages 12-17) is 21 times greater from COVID-19 than from vaccines.

Studies highlight ‘unprecedented and unique dangers’ for children during COVID-19

Two new studies investigating child maltreatment during the COVID-19 pandemic reveal “concerning results” that confirm warning signs seen early in the pandemic, according to researchers at UAB and the University of Michigan.

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.

Just in time for children returning to school this fall, Baylor Scott & White Health has launched an at-home monitoring service for children diagnosed with COVID-19.

Just in time for children returning to school this fall, Baylor Scott & White Health has launched an at-home monitoring service for children diagnosed with COVID-19. The service has been offered for adults since April. If you are interested in…

Baylor Scott & White Health Launches Digital At-Home Monitoring for Children Diagnosed with COVID-19

Baylor Scott & White Health has launched expanded digital care options via the MyBSWHealth app and online portal to provide support for children who have been diagnosed with COVID-19. Digital at-home monitoring has been available for adults ages 18 and older since May